MYRBETRIQ ER 25 MG TABLET

mirabegron
$14.6977per EA

Strength

25 mg/1

NDC

00469260130

Classification

Brand

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Active Ingredients

MIRABEGRON

Approval Type

New Drug (NDA)

FDA Application

NDA202611

On Market Since

6/28/2012

Pharmacological Classes

Adrenergic beta3-Agonists
Cytochrome P450 2D6 Inhibitors
Cytochrome P450 3A Inhibitors
P-Glycoprotein Inhibitors
beta3-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.1%

3M

-0.0%

6M

-0.0%

1Y

-0.1%

3Y

+2.8%

5Y

+10.2%

All

+100.6%